Search for: "Hoffmann-La Roche, Inc." Results 21 - 40 of 128
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Mar 2016, 3:23 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences. [read post]
7 Mar 2016, 1:55 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences.Never too late 83 [week ending on Sunday 14 February] – Indigenous IP | Arnold J's latest judgment flags down the iconic London black cab | Life of a national/EU trade mark ... in a map | A… [read post]
29 Feb 2016, 11:27 pm
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences.Never too late 83 [week ending on Sunday 14 February] – Indigenous IP | Arnold J's latest judgment flags down the iconic London black cab | Life of a national/EU trade mark ... in a map | A… [read post]
23 Feb 2016, 1:53 am
Hoffmann-La Roche AG and Genentech Inc. [read post]
17 Feb 2016, 12:19 am
Hoffmann-La Roche AG and Genentech Inc. [2016] EWHC 188 (Pat) come across her desk a few weeks ago. [read post]
11 Feb 2015, 12:23 pm
Bayer’s predecessor, Hoffmann-La Roche, filed a US application for FLANAX in February 2004. [read post]
12 Apr 2014, 6:39 am by Lawrence B. Ebert
Hoffman-LaRoche and Genentech cases on BonivaHoffman-LaRoche lost its appeal at the CAFC:Plaintiff Hoffmann-La Roche, Inc., (“Roche”) appealsfrom the decision of the United States District Court forthe District of New Jersey granting the defendant genericdrug companies summary judgment of invalidity as toclaims 1-8 of U.S. [read post]
19 Mar 2014, 9:00 am by Paula Bremner
It has been 15 years since the last brand v brand challenge of a biologic patent in Canada. [read post]
27 Feb 2014, 9:38 am by Dennis Crouch
Cir. 2009) and In re Hoffmann-La Roche, 587 F.3d 1333 (Fed. [read post]
19 Aug 2013, 11:47 am by Seyfarth Shaw LLP
  In every collective action, it is important to stress at the outset that the Court has discretion under Hoffmann-La Roche to refuse to authorize the sending of notice, and that heightened scrutiny of the evidence is appropriate when the factual record demonstrates that individual issues will prevent the case from ever being tried as a collective action. [read post]
23 Apr 2013, 3:17 am by Andrew Trask
The Court immediately rejected any attempt to use Rule 23 cases to support a wider ruling in Symczyk: But these cases are inapposite, both because Rule 23 actions are fundamentally different from collective actions under the FLSA, see Hoffmann-La Roche Inc., 493 U. [read post]